iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
0.9032
+0.0322 (3.70%)
At close: Oct 12, 2026, 4:00 PM EDT
0.894397
-0.0088 (-0.97%)
After-hours: Oct 12, 2026, 7:41 PM EDT
iBio, Inc. Market Cap
iBio, Inc. has a market cap or net worth of $58.08 million as of October 12, 2026. It is the 29,286th most valuable company in the world and the 4,553rd biggest in the United States. Its market cap has increased by 274.72% in one year.
Market Cap
58.08M
Enterprise Value
-27.76M
1-Year Change
274.72%
Global Rank
Country Rank
#4,553 United States
Category
ChartMarket Cap Chart
Since November 16, 2009, iBio, Inc.'s market cap has increased from $27.70M to $58.08M, an increase of 109.68%. That is a compound annual growth rate of 4.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 58.08M | 33.83% |
| Dec 31, 2025 | 43.40M | 93.75% |
| Dec 31, 2024 | 22.40M | 1,078.95% |
| Dec 29, 2023 | 1.90M | -52.50% |
| Dec 30, 2022 | 4.00M | -96.66% |
| Dec 31, 2021 | 119.70M | -37.40% |
| Dec 31, 2020 | 191.20M | 2,320.25% |
| Dec 31, 2019 | 7.90M | -43.57% |
| Dec 31, 2018 | 14.00M | -14.63% |
| Dec 29, 2017 | 16.40M | -53.41% |
| Dec 30, 2016 | 35.20M | -18.71% |
| Dec 31, 2015 | 43.30M | -12.17% |
| Dec 31, 2014 | 49.30M | 128.24% |
| Dec 31, 2013 | 21.60M | -27.03% |
| Dec 31, 2012 | 29.60M | 10.04% |
| Dec 30, 2011 | 26.90M | -73.23% |
| Dec 31, 2010 | 100.50M | 298.81% |
| Dec 31, 2009 | 25.20M | -9.03% |
| Nov 16, 2009 | 27.70M | - |
View and export this data all the way back to 2009. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| RenovoRx | 57.77M |
| Boundless Bio | 57.55M |
| Gossamer Bio | 56.94M |
| Alterity Therapeutics | 56.76M |
| Kalaris Therapeutics | 56.18M |
| Mereo BioPharma Group | 55.88M |
| Eloxx Pharmaceuticals | 55.46M |
| Aldeyra Therapeutics | 55.28M |